Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Formerly About Advanced Micro Devices -- Ignore unavailable to you. Want to Upgrade?

To: joseffy who wrote (697676)	2/10/2013 10:00:31 AM
From: FJB	1 Recommendation Respond to of 1574102

Eye surgeon linked with Sen. Bob Menendez frequently prescribed expensive drug, billed Medicare 9:33 PM 02/07/2013 Read more: dailycaller.com A federal criminal investigation into a West Palm Beach eye surgeon with close ties to a U.S. senator centers on the doctor’s billing of Medicare for millions of dollars to treat elderly patients suffering vision loss who may not have needed the costly services he administered, The Miami Herald has learned. For the past year, federal agents have been investigating the medical practice of Dr. Salomon Melgen, who sources familiar with the inquiry say is suspected of overbilling the taxpayer-funded program through frequent use of a high-priced drug called Lucentis, which is injected into patients’ eyes. Several sources familiar with the doctor’s practice said he used the drug, which costs $2,000 a vial, to treat patients with macular degeneration more than any other ophthalmologist in Florida and possibly the country. His high patient volume also raised red flags for investigators, the sources said. Under Medicare policies, a doctor may only prescribe treatment that is “reasonable” and “necessary.” To make a case, federal prosecutors would have to prove that Melgen needlessly treated patients simply to run up sky-high Medicare bills. Full story: South Florida eye surgeon under scrutiny with Sen. Menendez frequently prescribed expensive drug